By Forum Staff
State Attorney General Tish James on Friday announced a multistate settlement in principle with opioid manufacturer Amneal Pharmaceuticals for its role in fueling the nationwide epidemic of opioid addictions and overdoses.
The settlement in principle, which was negotiated by James and the attorneys general of California, Delaware, Tennessee, Utah, and Virginia, will provide $92.5 million in cash over 10 years and $180 million worth of naloxone nasal spray, an overdose treatment medication, to participating states and local governments.
File Photo
The settlement will also provide naloxone nasal spray, an overdose treatment medication, to participating states and local governments.
Amneal produces several generic opioid products and was one of the largest manufacturers of opioids from 2006 to 2019, selling nearly nine billion pills. James and a multistate coalition of attorneys general allege that Amneal knowingly failed to monitor and report suspicious orders placed by its customers, as it was required to by federal law.
Since James became the Empire State’s attorney general, opioid manufacturers, distributors, and marketers have paid over $2.7 billion to NY in settlement funds.
“Amneal became one of the largest generic pharmaceutical companies in the world by profiting off the sale of dangerous opioids,” James said. “While this settlement can’t fully reverse the damage done as a result of the national crisis, it will provide essential funding and resources for New York and other states to ensure those suffering get the help they need. I am proud to have secured over $2.7 billion to tackle the opioid epidemic in New York, and my office will continue to hold accountable the companies responsible for fueling this crisis.”
